Novel nanopolymer RNA therapeutics normalize human diabetic corneal wound healing and epithelial stem cells
- 10 November 2020
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 32, 102332
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute
- National Cancer Institute
This publication has 60 references indexed in Scilit:
- BMP7 Gene Transfer via Gold Nanoparticles into Stroma Inhibits Corneal Fibrosis In VivoPLOS ONE, 2013
- MiR-410 regulates MET to influence the proliferation and invasion of gliomaThe International Journal of Biochemistry & Cell Biology, 2012
- Gene therapy in the Cornea: 2005–presentProgress in Retinal and Eye Research, 2012
- Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug releaseProceedings of the National Academy of Sciences, 2010
- Normalization of Wound Healing and Diabetic Markers in Organ Cultured Human Diabetic Corneas by Adenoviral Delivery ofc-MetGeneInvestigative Ophthalmology & Visual Science, 2010
- Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A reviewBrain Research Bulletin, 2010
- Nanoconjugate based on polymalic acid for tumor targetingChemico-Biological Interactions, 2008
- Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(β-l-malic acid)Journal of Controlled Release, 2007
- Proteinase and Growth Factor Alterations Revealed by Gene Microarray Analysis of Human Diabetic CorneasInvestigative Ophthalmology & Visual Science, 2005
- Activities of the Matrix Metalloproteinase Stromelysin-2 (MMP-10) in Matrix Degradation and Keratinocyte Organization in Wounded SkinMolecular Biology of the Cell, 2004